Markets
DENMARK-INFORMATION-TECHNOLOGY-COMPUTER-AI
CEO of Nvidia, Jensen Huang (Mads Claus Rasmussen/Ritzau Scanpix/Getty Images)

Nvidia’s earnings report is the biggest market event left in 2024

The options market expects a bigger stock-market move from Nvidia’s earnings than upcoming jobs numbers, inflation data, or the Federal Reserve meeting.

Nvidia isn’t the best-performing stock in the S&P 500 this year, but it is the most important driver of the US benchmark index’s massive gains.

The chip designer singlehandedly accounts for about 23% of the S&P 500’s total return year to date, nearly as much as the rest of the Magnificent 7 combined.

And with the broader upswing in semiconductors faltering, there’s a lot of pressure on Nvidia to deliver when it reports quarterly results on Wednesday after the close. Analysts are looking for earnings per share of $0.74, and the company’s outlook will be closely scrutinized for signs on how much staying power is in the AI spending binge and how the deployment of its new Blackwell chip is going.

In a note on Sunday, Bank of America analysts led by Gonzalo Asis flagged how this company-specific event is also “a very big deal for the broader market.”

“The implied move for the S&P 500 on that day has been fluctuating with Nvidia’s own earnings implied move,” they write. “And options are assigning more broad market risk around Nvidia earnings than around next month’s non-farm payrolls and CPI days, and as much as the December FOMC.”

In other words, the options market is calling this the most important event left this year. 

BofA2024events
Source: Bank of America
SPXNVDAimpliedmove
Source: Bank of America

That same options market is showing signs of bullish sentiment on Nvidia through Christmas.

Looking at some metrics from Nations Indexes, the CallDex on the stock (how expensive purchasing one-month out-of-the-money upside is) is higher than the PutDex (the same thing, but for options that protect against drops) as of 10:24 a.m. ET today.

NationsNvidiaCallDex
Source: Nations Indexes

For the Friday expiry in particular, there’s far more open interest in out-of-the-money calls than out-of-the-money puts. Combined with the relative pricing of these options — a 5% out-of-the-money call has a higher implied volatility than a 5% out-of-the-money put option — this implies traders are optimistic on the outcome of Wednesday’s big event. 

Bank of America’s team, however, sees opportunities on the other side of the trade.

“Given single stock fragility on the rise and easing post-election euphoria, we find it sensible to hedge the potential added impact on the broader market in case Nvidia disappoints,” they conclude.

More Markets

See all Markets
$8.5T

Analysts at consulting firm Pantheon Macroeconomics estimate that the stock market’s enthusiasm for all things AI has added some $8.5 trillion to aggregate US household wealth since late 2022. They wrote:

“The S&P 500 returned about 70% between the start of ChatGPT mania around the end of 2022 to the end of Q2 2025, with roughly half of those returns generated by the ‘magnificent seven’ tech stocks, a very rough proxy for the stock market boost from AI euphoria.

We estimate that translates into a lift to household wealth held in stocks of about $8.5T.”

As my colleague Luke Kawa recently wrote, stock market wealth seems to be underpinning US consumer spending, especially among the richest Americans. Some of that spending may retrench if AI is indeed a bubble — as some have recently mooted — and eventually pops.

markets

Serve Robotics spikes after announcing multiyear partnership with DoorDash for deliveries

Serve Robotics is spiking in early trading after the maker of sidewalk delivery robots and DoorDash announced a “multi-year strategic partnership to roll out autonomous robot vehicles across the US,” starting with Los Angeles.

Serve already does restaurant deliveries in Los Angeles (as well as Miami, Dallas, Chicago, and Atlanta) thanks to its partnership with Uber Eats.

DoorDash, for its part, already utilizes Coco Robotics to deliver food in Los Angeles and Chicago. Last week, it debuted its own delivery robot called “Dot,” which can operate on roads and sidewalks and is designed for suburban environments, per the company. Dot will initially be trialed in Tempe and Mesa, Arizona.

Read more: A day in the life of a Serve food-delivery robot

markets

Novo Nordisk to acquire liver disease drugmaker Akero Therapeutics for up to $5.2 billion

Novo Nordisk announced Thursdsay that it intends to acquire Akero Therapeutics for up to $5.2 billion.

Novo said it would pay $54 per share for Akero, a 15% premium to its $46.49 closing price in Wednesday, for a total of $4.7 billion.

Akero’s efruxifermin (EFX) treats a liver disease known as MASH, or metabolic dysfunction-associated steatohepatitis. The company is currently conducting late-stage trials of the drug. Shareholders will receive another $500 million if US regulators approve EFX to treat compensated cirrhosis brought about by MASH.

Akero rose about 18% in premarket trading.

Roche announced in September that it would buy another MASH drugmaker, 89bio, for $2.4 billion. GSK in July completed a $1.2 billion deal to license Boston Pharmaceuticals MASH drug.

Novo, the maker of Ozempic and Wegovy, has been struggling to spark sales growth amid increased competition from other weight-loss drugs and copycat versions of its drugs. The Danish drugmaker, which is down more than 30% for the year, slipped about 1% in premarket trading.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.